PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Psychiatria XX wieku w Europie Zachodniej i USA - próba retrospekcji

Autorzy
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
EN
Twentieth-century psychiatry in Western Europe and the USA - an attempt at a retrospection
Języki publikacji
PL
Abstrakty
EN
The article analyzes various areas of twentieth-century psychiatry: (1) a number of ideas whose roots date to the second half of the 19th century, including the ideas of biological psychiatry, constitutional psychiatry and behavioural therapy; (2) the emergence of a modem paradigm of mental disease and the contribution made to that field by Kraepaelin and Bleuler; (3) attempts to find new effective solutions, especially with regard ot biological therapy; (4) an overview of the problems and dilemmas of contemporary psychiatry. Special emphasis has been put in the article on the stages and dimensions of the socalled ’’psychopharmacological revolution” and the history of the development of various groups of psychiatric drugs (chlorpromazine and the first psychiatric drugs, soporifics and sedatives, antidepressants). The author makes an attempt to point out the fundamental dilemmas of contemporary psychiatry, especially the dangers it faces from other branches of medicine and non-medical disciplines, as well as from mass culture and commercialization.
Twórcy
autor
  • WFiS UMCS Lublin
Bibliografia
  • 1. G. E. Berrios : The History of Mental Symptoms. Cambridge 1997 Cambridge University Press, s. 16.
  • 2. E. Shorter: A History of Psychiatry. New York 1997 John Wiley & Sons, Inc.
  • 3. E. Kraepelin: Lebenserinnerungen. Berlin 1983 Springer s. 11-12.
  • 4. E. Baumler: Wielkie leki. Warszawa 1995 Iskry, s. 5.
  • 5. H. Lehman: The Introduction of Chlorpromazine to North America, „Psychiatric Journal of the University of Ottawa” 1989
  • 6. Judith P. Swazey : Chlorpromazine in Psychiatry. A Study of Therapeutic Innovation. Cambridge, Massachusetts, and London 1974 The MIT Press, s. 96.
  • 7. A. Caldwell: History of Psychofarmacology. [w:] Principles of Psychofarmacology. Eds. W. C. Clark i J. Del Giuidice New York 1978 Academic, s. 30.
  • 8. W. Overholser: Has Chlorpromazine Inaugurated a New Era in Mental Hospitals? „Journal of Clinical Psychopathology”, 1956 17 s. 199-200.
  • 9. H. Brill i R.E. Pallon : Analysis of population reduction in New York State mental hospitals during the first four years of large-scale therapy with psychotropic drugs. „American Journal of Psychiatry”, 1959 116 s. 496.
  • 10. G. L. KIerman : Assesing the Influence of the Hospital Milieu upon the Effectiveness of Psychiatric Drug Therapy: Problems of Conceptualization and Research Methodology. „Journal of Nervous and Mental Diseases”, 1963 137: s. 144-145.
  • 11. D.F. Papolos : Przezwyciężyć depresję. Poznań 1998 Rebis s. 153.
  • 12. G. Wilkinson : Talking about Psychiatry. London 1993 Gaskell s. 167.
  • 13. L.J. Pongratz: Psychiatrie in Selbstdarstellungen. Beme 1977 Huber s. 219-257.
  • 14. E. Baumler : Wielkie leki, s. 321.
  • 15. A.C. Higgitt, M.H. Lader, P. Fonagy : Clinical Management of benzodiazepine dependence. „British Medical Journal”, 1985 291 s. 688-690.
  • 16. Niedatowany wywiad z Coppenem przeprowadzony przez D. Healy; cytuję za: E. Shorter: A History of Psychiatry, s. 321.
  • 17. H.Y. Mellzeretal.: Extrapyramidal Side Effects and lncrised Serum Prolactin Following Fluoxetine, a New Antidepressant. „Journal of Neural Transmission”, 1979 45 s. 165-175.
  • 18. WEOS Radio 89.7 FM Genewa, New York 01.24.96.
  • 19. D.Healy: The History of British Psychopharmacology, [w:] 150 Years of British Psychiatry (tom II). Eds. H.FreemaniG.E.Berrios London 1996 Athlone s. 74.
  • 20. G.E. Berrios: The History of Mental Symptoms, s. 1.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-c8f843be-5c27-4438-b6c3-4802271016d6
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.